IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ALIBERTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.646
NA - Nord America 17.961
AS - Asia 16.675
SA - Sud America 1.853
AF - Africa 489
OC - Oceania 269
Continente sconosciuto - Info sul continente non disponibili 30
Totale 57.923
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.116
GB - Regno Unito 5.932
CN - Cina 5.387
IT - Italia 4.752
SG - Singapore 4.498
DE - Germania 2.840
RU - Federazione Russa 1.448
HK - Hong Kong 1.381
VN - Vietnam 1.261
BR - Brasile 1.239
SE - Svezia 1.235
FR - Francia 1.003
IN - India 730
IE - Irlanda 637
JP - Giappone 637
BD - Bangladesh 579
CA - Canada 578
NL - Olanda 547
FI - Finlandia 494
ES - Italia 455
KR - Corea 453
TR - Turchia 453
ID - Indonesia 386
UA - Ucraina 267
AU - Australia 219
CO - Colombia 172
TW - Taiwan 168
MX - Messico 162
DK - Danimarca 154
AR - Argentina 135
CI - Costa d'Avorio 132
BE - Belgio 127
CH - Svizzera 126
AT - Austria 113
GR - Grecia 111
EU - Europa 110
TH - Thailandia 110
ZA - Sudafrica 98
IQ - Iraq 96
PL - Polonia 88
CL - Cile 76
EC - Ecuador 71
SA - Arabia Saudita 70
PK - Pakistan 68
PE - Perù 64
PH - Filippine 54
PT - Portogallo 49
RO - Romania 47
IR - Iran 44
EG - Egitto 43
NZ - Nuova Zelanda 43
VE - Venezuela 39
MY - Malesia 38
UZ - Uzbekistan 36
IL - Israele 32
MA - Marocco 32
BO - Bolivia 31
NO - Norvegia 28
DZ - Algeria 27
JO - Giordania 26
KE - Kenya 25
TN - Tunisia 24
ET - Etiopia 23
HU - Ungheria 23
LU - Lussemburgo 23
LT - Lituania 22
CZ - Repubblica Ceca 20
AE - Emirati Arabi Uniti 18
DO - Repubblica Dominicana 18
LB - Libano 18
MD - Moldavia 17
NP - Nepal 16
CR - Costa Rica 15
PY - Paraguay 15
RS - Serbia 15
BG - Bulgaria 13
NG - Nigeria 13
KZ - Kazakistan 12
PA - Panama 12
AZ - Azerbaigian 11
JM - Giamaica 11
SN - Senegal 11
OM - Oman 10
PS - Palestinian Territory 10
HN - Honduras 9
UY - Uruguay 9
BB - Barbados 8
BH - Bahrain 8
EE - Estonia 8
QA - Qatar 8
SC - Seychelles 8
AL - Albania 7
GE - Georgia 7
MK - Macedonia 7
NI - Nicaragua 7
SK - Slovacchia (Repubblica Slovacca) 7
TT - Trinidad e Tobago 7
A2 - ???statistics.table.value.countryCode.A2??? 6
CM - Camerun 6
KG - Kirghizistan 6
Totale 57.860
Salva come PNG Salva come JPEG
Città #
Southend 5.139
Singapore 2.622
Ashburn 1.699
Hong Kong 1.229
Milan 1.191
Chandler 1.118
Hanover 1.087
Fairfield 1.031
San Jose 941
Beijing 832
Wilmington 670
Princeton 660
Seattle 641
Dublin 615
Council Bluffs 584
Dallas 579
Houston 576
Frankfurt am Main 570
Woodbridge 508
Ann Arbor 443
Los Angeles 403
Guangzhou 380
Cambridge 365
Ho Chi Minh City 350
New York 341
Santa Clara 337
Hanoi 322
Lauterbourg 302
Toronto 289
Hangzhou 280
Helsinki 265
Jakarta 251
Shanghai 249
Tokyo 249
Des Moines 245
Buffalo 238
Nanjing 234
Bengaluru 229
Redwood City 227
Moscow 222
Rome 212
Dearborn 207
Jacksonville 195
Istanbul 168
Munich 155
Seoul 152
Barcelona 147
Phoenix 143
Abidjan 131
São Paulo 130
Columbus 125
Hefei 125
Berlin 124
Redmond 124
Boardman 123
London 120
San Diego 119
The Dalles 118
Cangzhou 113
Tianjin 106
Chicago 103
Mountain View 100
Shenyang 94
Naples 93
Turin 91
Jinan 86
Atlanta 81
Bogotá 78
Florence 76
Paris 75
Nuremberg 74
Shenzhen 71
Taipei 71
Zhengzhou 71
Wuhan 70
Changsha 69
Brussels 68
Serra 66
Andover 65
Palermo 63
Bologna 61
Athens 60
Hebei 59
Madrid 59
Sakarya 59
Nanchang 58
Fuzhou 57
Montreal 56
Somerville 56
Melbourne 55
Dong Ket 54
Central District 52
Washington 52
Da Nang 51
Bangkok 49
Boston 48
Haiphong 48
Vienna 48
Santiago 47
Zurich 47
Totale 33.991
Salva come PNG Salva come JPEG
Nome #
Aspiration risk factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia 2.304
Validation of Murray sputum purulence scale in the Italian Registry of Bronchiectasis (IRIDE) 1.507
Bronchiectasis Rheumatoid Overlap Syndrome Is an Independent Risk Factor for Mortality in Patients with Bronchiectasis : A Multicenter Cohort Study 1.288
The Relationship Between Symptoms, Exacerbations and Treatment Response in Bronchiectasis 1.216
Mapping the human genetic architecture of COVID-19 1.112
Serotypes and antibiotic susceptibility of Streptococcus pneumoniae isolated from hospitalized patients with community-acquired pneumonia in Italy 698
A systematic review of the effect of delayed appropriate antibiotic treatment on the outcomes of patients with severe bacterial infections 666
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 619
A Cluster Analysis of Bronchiectasis Patients Based on the Airway Immune Profile 586
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients 571
Come scrivere un articolo scientifico = How to write a scientific paper 475
The Italian registry of pulmonary non-tuberculous mycobacteria : IRENE: The study protocol 405
Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response 405
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 401
Role of Streptococcus pneumoniae infection in chronic obstructive pulmonary disease patients in Italy 391
International perspective on the new 2019 ATS/IDSA CAP guideline - a critical appraisal by a global expert panel 370
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 356
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: an observational cohort study 353
A 13-year-old female with shortness of breath and pleuritic chest pain 344
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation 328
Management of drug toxicity in M. avium complex pulmonary disease - an expert panel survey 327
Comparison of different conditions for DNA extraction in sputum : A pilot study 325
Chest X-ray findings in a large cohort of 1117 patients with SARS-CoV-2 infection: a multicenter study during COVID-19 outbreak in Italy 323
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia 320
Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19 316
Response of an Italian reference institute to research challenges regarding a new pandemic: COVID-19 network 302
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 301
Non-Intensive Care Unit Acquired Pneumonia : A New Clinical Entity? 298
The biology of pulmonary exacerbations in bronchiectasis 295
Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective 293
Sputum neutrophil elastase in bronchiectasis: a Southern European cohort study 293
How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis 290
A real life evaluation of non invasive ventilation in acute cardiogenic pulmonary edema : a multicenter, perspective, observational study for the ACPE SIMEU study group 286
Neutrophil elastase in bronchiectasis 280
100 years of respiratory medicine : Pneumonia 276
The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis 275
Usefulness of simplified acute physiology score II in predicting mortality in patients admitted to an emergency medicine ward 273
An international perspective on hospitalized patients with viral community-acquired pneumonia 272
Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients 266
Management of Acute Respiratory Failure Due to Community-Acquired Pneumonia: A Systematic Review 258
Chlamydia pneumoniae and Mycoplasma pneumoniae 257
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia 256
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 256
Upper Respiratory Tract Microbiome and Otitis Media Intertalk : Lessons from the Literature 251
Complement activation in patients with COVID-19: a novel therapeutic target 249
Predictors of Helmet CPAP Failure in COVID-19 Pneumonia: A Prospective, Multicenter, and Observational Cohort Study 247
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy 246
Hemostatic alterations in COVID-19 245
Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia 239
Azithromycin and lower respiratory tract infections 236
Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of anti-infective therapy (SITA) and the Italian Society of Pulmonology (SIP) 236
T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis 236
COVID-19 multidisciplinary high dependency unit: the Milan model 235
Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study 235
Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis 231
Plaque-related vs. plaque-unrelated cardio and cerebrovascular events (CCVE) in hospitalized patients with community-acquired pneumonia (CAP): Preliminary results from the FAILCAP study (ClinicalTrials: NCT01143155) 229
Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria 229
What is the best technique to extract bacterial DNA from sputum? 228
The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients 227
Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC) 226
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 226
Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis 226
Early detection of deep vein thrombosis in patients with coronavirus disease 2019 : who to screen and who not to with Doppler ultrasound? 224
Selection of Candidates for Lung Transplantation : The First Italian Consensus Statement 224
Acute effects of positive end-expiratory pressure on left ventricle diastolic function in healthy subjects 220
Phenotyping in bronchiectasis: are we moving toward a personalized medicine? 220
Severe pneumococcal pneumonia causes acute cardiac toxicity and subsequent cardiac remodeling 218
Pulmonary fibrosis secondary to COVID-19 : a call to arms? 218
Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice 217
The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease : A Cohort of Hospitalized Patients 217
Individualizing duration of antibiotic therapy in community-acquired pneumonia 216
Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques 216
Bronchiectasis in India : results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry 214
Antibiotic therapy and prophylaxis in COPD 213
Mortality in acute cardiogenic pulmonary edema treated with continuous positive airway pressure 213
COVID-19 In Lung Transplant Recipients: A Case Series From Milan, Italy 213
Polmoniti nosocomiali: dalle basi epidemiologiche alla terapia 212
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy : comment 212
The ADAMTS13-von Willebrand factor axis in COVID-19 patients 208
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 207
STEROIDS ARE NOT ASSOCIATED WITH AN IMPROVEMENT IN CLINICAL OUTCOMES IN HOSPITALISED PATIENTS WITH CAP 206
Noninvasive respiratory support outside the intensive care unit for acute respiratory failure related to coronavirus-19 disease : a systematic review and meta-analysis 206
Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement 204
Low CURB-65 is of limited value in deciding discharge of patients with community-acquired pneumonia 202
Bronchiectasis : an update 201
Formoterol fumarate + glycopyrrolate for the treatment of chronic obstructive pulmonary disease 201
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 198
Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis 197
Hospital-Acquired Pneumoniae 197
IN CIDENCE, RISK FACTORS AND OUTCOMES OF CARDIOVASCULAR EVENTS IN HOSPITALISED PATIENTS WITH CAP 197
Real-life evaluation of clinical outcomes in patients undergoing treatment for non-tuberculous mycobacteria lung disease: A ten-year cohort study 197
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis 197
Clinical characteristics and disease severity of adults with cystic fibrosis with at least one residual function mutation 196
The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients 196
Applicazione di una pressione positiva continua delle vie aeree 8CPAP) in un paziente trapiantato affetto da fibrosi polmonare idiopatica 195
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 195
The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study 194
Microbiological testing of adults hospitalised with community-acquired pneumonia : an international study 193
From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis 193
Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicenter, cohort study 192
Totale 33.349
Salva come PNG Salva come JPEG
Categoria #
all - tutte 162.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 162.063
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.111 0 0 0 0 0 0 0 0 0 0 601 510
2021/20226.581 418 497 427 338 426 414 821 719 698 520 391 912
2022/20235.604 722 534 444 558 456 981 311 368 514 130 370 216
2023/20244.436 192 335 283 362 771 349 355 264 212 303 465 545
2024/20258.830 460 902 266 840 611 526 450 885 645 738 950 1.557
2025/202616.869 1.449 967 1.702 1.347 1.704 1.286 2.249 1.159 2.037 1.320 1.649 0
Totale 60.399